Biography
Biography: Antonio Steardo
Abstract
By a side, genetic engineering raises several ethical questions on gene editing and manipulation. On the other hand, drug safety development should lead to assure pharmaceutical manufacturing gene engineering tools are safe as they are effective. Two steps seem to be important to obtain this feature. The first starts from in silico creating a target molecule. The second should combine the test on molecular mechanism in phase I and so on the evaluation of the bioengineered drug by phases II and III. Trail Safety as well as Efficacy must be the most important characteristic to assess. Along with these clinical processes in vivo, the study can be the first step to understanding the role of the bioengineered pharmaceutical tool in the mechanism. Safety and efficacy get close to those warnings about gene manipulation. They should be considered for what they generate properly.